Development of antibody technologies to produce novel therapeutic and diagnostic applications

Read full text Summarise with VIRAT
Authors: Sarah Lynn Seawright
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Problems with steroid analysis in a clinical lab have been well characterized over the years, and organizations have issued position statements and recommendations on androgen-disorder diagnostics. This research aims to discover and develop an antibody highly specific for testosterone with minimal cross-reactivity to DHEA and other steroids using a combination of classical hybridoma technologies and in silico engineering techniques. By assessing the docking energies of testosterone and other steroids to the selected antibody molecular dynamics was employed to observe potential conformational changes in the binding process. This information will aid in further developing the antibody for affinity maturation and specificity optimization. Thesis is embargoed until 31 December 2028.

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research vaccines and immunoinformatics approaches Computational Drug Discovery Methods

Publication details

Journal / source
Research Portal (Queen's University Belfast)
Publication date
1 October 2026
Language
EN
Document type
Thesis